Dayvigo 5mg Tablet

Dayvigo 5mg tablet contains an active component as Lemborexant. This medication belongs to the orexin receptor antagonist class, which generally has a lower risk of physical dependence and withdrawal symptoms compared to traditional sleep medications like benzodiazepines and some other sedative-hypnotics. This medication is a medication used for the treatment of insomnia, a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep. Dayvigo 5mg tablet can help individuals with insomnia fall asleep faster and stay asleep longer. It may reduce the time it takes to fall asleep and decrease the number of awakenings during the night, leading to a more restful sleep experience.  By promoting better sleep quality and duration, this medication can help reduce daytime sleepiness and fatigue. This can improve daytime functioning, cognitive performance, and overall well-being. If an individual has a known allergy or hypersensitivity to the Dayvigo 5mg tablet or its components, its use should be avoided. Inform your healthcare provider about any pre-existing medical conditions, such as gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may require special precautions or adjustments in the use of this medication. Older adults may be more sensitive to the effects of Dayvigo 5mg tablet, including drowsiness and impaired coordination.  Individuals with severe respiratory impairment, including conditions like obstructive sleep apnea, may be at a higher risk of respiratory depression when taking it. The medication should be used cautiously and under close medical supervision in these cases. This medication should be used cautiously in individuals with a history of sleep-related breathing disorders due to the potential for worsening these conditions.